Q1 2022 13F Holders as of 31 Mar 2022
-
Type / Class
-
Equity / SHS
-
Total 13F shares
-
41,681,123
-
Share change
-
+334,847
-
Total reported value
-
$387,637,985
-
Put/Call ratio
-
665%
-
Price per share
-
$9.30
-
Number of holders
-
95
-
Value change
-
-$6,203,662
-
Number of buys
-
50
-
Number of sells
-
37
Institutional Holders of FORMA THERAPEUTICS HLDGS INC - SHS (FMTX) as of Q1 2022
As of 31 Mar 2022,
FORMA THERAPEUTICS HLDGS INC - SHS (FMTX) was held by
95 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
41,681,123 shares.
The largest 10 holders included
RA CAPITAL MANAGEMENT, L.P., Cormorant Asset Management, LP, ARMISTICE CAPITAL, LLC, BlackRock Inc., STATE STREET CORP, VANGUARD GROUP INC, BAKER BROS. ADVISORS LP, Deep Track Capital, LP, Samsara BioCapital, LLC, and FMR LLC.
This page lists
95
institutional shareholders reporting positions in this security
for the Q1 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.